<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">46689</article-id><article-id pub-id-type="doi">10.7554/eLife.46689</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>FcγRIIB-I232T polymorphic change allosterically suppresses ligand binding</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-135320"><name><surname>Hu</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135321"><name><surname>Zhang</surname><given-names>Yong</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-76581"><name><surname>Sun</surname><given-names>Xiaolin</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-148460"><name><surname>Zhang</surname><given-names>Tongtong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135322"><name><surname>Xu</surname><given-names>Liling</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135323"><name><surname>Xie</surname><given-names>Hengyi</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-76582"><name><surname>Li</surname><given-names>Zhanguo</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-135112"><name><surname>Liu</surname><given-names>Wanli</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0395-2800</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-135324"><name><surname>Lou</surname><given-names>Jizhong</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-76578"><name><surname>Chen</surname><given-names>Wei</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5366-7253</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Neurobiology, Institute of Neuroscience</institution>, <institution>Zhejiang University School of Medicine</institution>, <addr-line><named-content content-type="city">Zhejiang</named-content></addr-line>, <country>China</country></aff><aff id="aff2"><institution content-type="dept">CAS Center for Excellence in Biomacromolecules</institution>, <institution>Institute of Biophysics, Chinese Academy of Sciences</institution>, <addr-line><named-content content-type="city">Beijing</named-content></addr-line>, <country>China</country></aff><aff id="aff3"><institution content-type="dept">Department of Rheumatology and Immunology</institution>, <institution>Peking University People's Hospital</institution>, <addr-line><named-content content-type="city">Beijing</named-content></addr-line>, <country>China</country></aff><aff id="aff4"><institution content-type="dept">Institute for Immunology</institution>, <institution>Tsinghua University</institution>, <addr-line><named-content content-type="city">Beijing</named-content></addr-line>, <country>China</country></aff><aff id="aff5"><institution content-type="dept">School of Life Sciences</institution>, <institution>Tsinghua University</institution>, <addr-line><named-content content-type="city">Beijing</named-content></addr-line>, <country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-61967"><name><surname>Kurosaki</surname><given-names>Tomohiro</given-names></name><role>Reviewing editor</role><aff><institution>Osaka University</institution>, <country>Japan</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>liulab@tsinghua.edu.cn</email> (WL);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>jlou@ibp.ac.cn</email> (JL);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>jackweichen@zju.edu.cn</email> (WC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>25</day><month>07</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e46689</elocation-id><history><date date-type="received"><day>08</day><month>03</month><year>2019</year></date><date date-type="accepted"><day>25</day><month>07</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Hu et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Hu et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-46689-v1.pdf"/><abstract><p>FcγRIIB binding to its ligand suppresses immune cell activation. A single-nucleotide polymorphic (SNP) change, I232T, in the transmembrane (TM) domain of FcγRIIB loses its suppressive function, which is clinically associated with systemic lupus erythematosus (SLE). Previously, we reported that I232T tilted FcγRIIB's TM domain. In this study, combining with molecular dynamics simulations and single-cell FRET assay, we further reveal that such tilting by I232T unexpectedly bends the FcγRIIB's ectodomain towards plasma membrane to allosterically impede FcγRIIB's ligand association. I232T substitution reduces <italic>in-situ</italic> two-dimensional binding affinities and association rates of FcγRIIB to interact with its ligands, IgG1, IgG2 and IgG3 by three to four folds. This allosteric regulation by a SNP provides an intrinsic molecular mechanism for the functional loss of FcγRIIB-I232T in SLE patients.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Natural Basic Research Program of China</institution></institution-wrap></funding-source><award-id>2015CB910800</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Wei</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31470900</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Wei</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31522021</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Wei</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>11672317</award-id><principal-award-recipient><name><surname>Lou</surname><given-names>Jizhong</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>11772348</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Yong</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Fundamental Research Founds for the Central Universities</institution></institution-wrap></funding-source><award-id>2015XZZX004-32</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Wei</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The ethics committee of Peking University People's Hospital approved this study and informed consents were obtained from each patient and healthy volunteer. All the human cell associated  experimental guidelines were approved by the Medical Ethics Committee of Peking University  People's Hospital (approval no. 2014PHB116-01) and by the Medical Ethics Committee of Tsinghua  University (approval no. 20180029).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><supplementary-material><ext-link xlink:href="elife-46689-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>